Market Currents
Shares of Telik (TELK +57.2%) are soaring on heavy volume following a brief halt after the FDA...
-
Friday, January 11, 1:48 PM ETShares of Telik (TELK +57.2%) are soaring on heavy volume following a brief halt after the FDA grants orphan drug status for Telintra, a treatment for myelodysplastic syndrome.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
